Detailseite
Projekt Druckansicht

Identifizierung und Validierung zellulärer Schlüsselfaktoren die die SarsCoV2 Assemblierung katalysieren und deren Einfluss auf die neuronale Proteostase

Fachliche Zuordnung Virologie
Förderung Förderung von 2021 bis 2022
Projektkennung Deutsche Forschungsgemeinschaft (DFG) - Projektnummer 458698796
 
Erstellungsjahr 2022

Zusammenfassung der Projektergebnisse

In this one-year project we generated highly potent antibodies against several SARS-CoV2 proteins, proved their specificity and used them to establish a reliable in-cell ELISA, i.e. an immunological assay equivalent to a functional bioassay measuring infectivity and validated against such infectivity assays of all relevant SARS-CoV2 strains, including alpha, beta, delta, and omikron 1. We used this assay to screen a number of novel anti-SARS-CoV2 drugs, namely those that do not target the virus itself but host factors that SARS-CoV2 recruits for its replication and that, if inhibited by those drugs, concurrently inhibit SARS- CoV2. The lead compound #431 was effective at around 100 nM in Calu-3 cells in a doseresponse relationship and, by drug affinity chromatography was demonstrated to interact with a protein complex containing proteins p62/SQSTM1, VCP/p97, 14-3-3, and CAPN2. Yet more chemical analogues were shown to be of variable effectiveness allowing the establishment of a structure-activity-relationship and hence proving specificity of the compound. SARS-CoV2 was shown to increase tau phosphorylation in a neuroblastoma cell line overexpressing mutant tau which was prevented by the presence or absence of virus indicating that the targeted host proteins mediate cellular pathology associated to neurotoxicity. A future continuation of this project will focus on using #431 in an animal trial of SARS-CoV2 infection, and further characterize the significance of the candidate proteins targeted by #431, and possible induced cellular pathology.

Projektbezogene Publikationen (Auswahl)

 
 

Zusatzinformationen

Textvergrößerung und Kontrastanpassung